Business Context and Reporting Period
Company: Spectral AI, Inc. (MDAI)
Filing Type: Form 8-K (Current Report)
Date of Report: December 12, 2024
Event: Entry into a Material Definitive Agreement and execution of a Registered Direct Offering.
Key Financial Metrics
This filing reports a specific capital raise transaction rather than periodic financial performance metrics (e.g., revenue, net income, or operating cash flow).
- Transaction Date: December 12, 2024
- Shares Issued: 500,000 shares of Common Stock
- Offering Price: $1.80 per share
- Gross Proceeds: $900,000 (500,000 shares x $1.80)
- Total Commitment Capacity: Up to $5,000,000 in aggregate proceeds under the Purchase Agreement
Material Changes and Transaction Details
On November 18, 2024, the Company entered into a Securities Purchase Agreement with an investor. On December 12, 2024, the investor delivered a purchase notice for the initial tranche of 500,000 shares. The transaction was conducted pursuant to a Registration Statement on Form S-3 declared effective on October 31, 2024.
Key Terms of the Agreement:
- Option for Additional Shares: The investor holds an option to purchase additional shares up to the lesser of $5,000,000 in aggregate proceeds or the remaining available capacity based on one-third of the public float.
- Pricing Mechanism: Additional shares will be priced at the lesser of the previous trading day's closing price or the 5-day volume-weighted average price.
- Right of First Refusal: The investor has been granted a right of first refusal for any equity offering during the period from the agreement's effective date until ten business days after the investor purchases securities equal to the Commitment Amount.
Guidance, Outlook, and Risks
Use of Proceeds: The filing mentions the intended use of proceeds as a forward-looking statement but does not specify the exact allocation in this text.
Risks and Contingencies:
- The report contains forward-looking statements subject to uncertainties and risks outside the Company's control.
- Investors are directed to the "Risk Factors" section of the Company's Form 10-K for the year ended December 31, 2023, for a discussion of factors that could cause actual results to differ materially.
- The Company undertakes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the total number of shares outstanding post-issuance to assess dilution impact.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and conditions.
- Confirm the Company's current public float to calculate the maximum potential proceeds under the "one-third of public float" limitation.
- Examine the Form 10-K filed on March 29, 2024, for detailed risk factors and historical financial context.
- Monitor subsequent filings for the exercise of the option to purchase additional shares up to the $5,000,000 commitment.